Pain News and Research

Latest Pain News and Research

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.

22 Jul 2011

Roundup: Ore. cuts insurer's rate increase; Ga.'s effort to curb TB struggles; psychiatric care hard to get in Boston

The Oregon Insurance Division will allow the state's largest health insurer to raise rates on individual premiums an average 12.8 percent, far lower than the 22.1 percent the company had requested.

22 Jul 2011

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

Sapheon Inc. announced successful enrollment in a 30-patient, prospective, single-arm clinical study of the Sapheon Closure System — a single-use, minimally invasive approach to the treatment of saphenous vein reflux disease.

22 Jul 2011

FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA

Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet Oral Solution distributed by FSC Laboratories, Inc.

22 Jul 2011

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

22 Jul 2011

High cost of multiple sclerosis drugs

According to a study released this Wednesday, drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost.

21 Jul 2011

Pharmaceutical waste forms a whole new range of contaminants

The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.

21 Jul 2011

Researchers discover novel combination of two mutations in a patient with ADHD

Often enough, in science as in life, unexpected knowledge has a personal impact. Researchers seeking rare gene variants in just a few individuals with attention-deficit hyperactivity disorder (ADHD) discovered that one patient had a novel combination of two mutations.

21 Jul 2011

Experts to explore wound healing abilities of dolphins

A Georgetown University Medical Center (GUMC) scientist who has previously discovered antimicrobial compounds in the skin of frogs and in the dogfish shark has now turned his attention to the remarkable wound healing abilities of dolphins.

21 Jul 2011

Alliqua acquires global license for wound care dressings from Noble Biomaterials

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.

21 Jul 2011

Dealing with chronic pain

For people with severe chronic pain like Kelly Young and Teresa Shaffer—both of whom have become patient advocates —coping with agony is a fact of life. Young suffers from rheumatoid arthritis while Shaffer's pain is linked primarily to another degenerative bone disease.

21 Jul 2011

Caltech, Zcube collaboration will bring painless transdermal drug delivery to patients

Zcube Srl, a research venture of the Italian pharmaceutical company Zambon, and the California Institute of Technology (Caltech) have signed an exclusive research and option agreement to develop and commercialize skin patches that contain embedded carbon nanotubes for delivering drugs. The patches will first be developed to painlessly administer drugs through the skin; other applications are envisioned for future use. Mory Gharib, Hans W. Liepmann Professor of Aeronautics and professor of bioinspired engineering, is the principal investigator at Caltech.

21 Jul 2011

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

For the fifth straight year, The University of Texas MD Anderson Cancer Center is the leading hospital in the nation for cancer care, according to the "Best Hospitals" survey published annually by U.S. News & World Report magazine.

21 Jul 2011

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts. The test may eventually help some patients avoid needless surgery to remove the harmless variety.

21 Jul 2011

Pfizer enters definitive merger agreement with Icagen

Pfizer Inc. and Icagen, Inc. today announced that they have entered into a definitive merger agreement. Pfizer, which currently owns approximately 11% of Icagen's fully diluted shares, will acquire the remaining 8.3 million shares at a price of $6.00 per share.

21 Jul 2011

DJO Global launches Turon Modular Shoulder System

DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the introduction of the Turon Modular Shoulder System developed by the Company's surgical division, DJO Surgical.

20 Jul 2011

Kool Smiles inaugurates new Elkhart office to offer dental services

Kool Smiles, a leading dental health provider for children and adults, has opened a new office in Elkhart. Kool Smiles of Elkhart, which began seeing patients on July 11, puts quality dental care within reach of even more previously underserved area residents.

20 Jul 2011

Pain News and Research

Latest Pain News and Research

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Roundup: Ore. cuts insurer's rate increase; Ga.'s effort to curb TB struggles; psychiatric care hard to get in Boston

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

High cost of multiple sclerosis drugs

Pharmaceutical waste forms a whole new range of contaminants

Researchers discover novel combination of two mutations in a patient with ADHD

Experts to explore wound healing abilities of dolphins

Alliqua acquires global license for wound care dressings from Noble Biomaterials

Dealing with chronic pain

Caltech, Zcube collaboration will bring painless transdermal drug delivery to patients

U.S. News ranks University of Texas MD Anderson as leading hospital for cancer care

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

Pfizer enters definitive merger agreement with Icagen

DJO Global launches Turon Modular Shoulder System

Kool Smiles inaugurates new Elkhart office to offer dental services

Young people with serious genetic blood disorder are not getting right help at school

Women with breastfeeding difficulties may experience postpartum depression

High rates of osteoarthritis in athletes linked to femur damage during adolescence

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pain News and Research

Latest Pain News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in